Massive study to monitor lupus drug safety in millions of young women
NCT ID NCT07431775
Summary
This study aims to understand how young women of childbearing age use the lupus drug Saphnelo (anifrolumab) in real-world settings. It will track treatment patterns and gather safety information, particularly regarding pregnancy, by reviewing existing health records from millions of patients in the US and Europe. The goal is to fulfill a regulatory requirement to better understand the drug's use in this specific population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.